Browse by People

Collapse authors list.
Pettitt, AR, Polydoros, F, Dodd, J, Oates, M, Lin, K, Kalakonda, N, McCarthy, H, Bloor, A, Schuh, A, Duncombe, A et al (show 6 more authors) , Dearden, C, Fegan, C, Kennedy, B, Yap, C, Coupland, SE ORCID: 0000-0002-1464-2069 and Hillmen, P (2016) FINAL RESULTS OF THE NCRI CLL210 TRIAL OF ALEMTUZUMAB, DEXAMETHASONE AND LENALIDOMIDE IN PATIENTS WITH HIGH-RISK CLL (ORIGINAL PROTOCOL). .

Collapse authors list.
Eyre, TA, Clifford, R, Bloor, A, Boyle, L, Roberts, C, Cabes, M, Collins, GP, Devereux, S, Follows, G, Fox, CP et al (show 12 more authors) , Gribben, J, Hillmen, P, Hatton, CS, Littlewood, TJ, McCarthy, H, Murray, J, Pettitt, AR, Soilleux, E, Stamatopoulos, B, Love, SB, Wotherspoon, A and Schuh, A (2016) NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome. BRITISH JOURNAL OF HAEMATOLOGY, 175 (1). pp. 43-54.

Collapse authors list.
Munir, T, Howard, DR, McParland, L, Pocock, C, Rawstron, AC, Hockaday, A, Varghese, A, Hamblin, M, Bloor, A, Pettitt, A et al (show 5 more authors) , Fegan, C, Blundell, J, Gribben, JG, Phillips, D and Hillmen, P (2017) Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL. LEUKEMIA, 31 (10). pp. 2085-2093.